TW-37, a small molecule inhibitor of B-cell lymphoma 2 (Bcl-2) family proteins [85], enhanced the pro-apoptosis and anti-migration ability of gefitinib in NSCLC [86]. Here, BCL2 is linked to non-small cell lung carcinoma.